Voya Investment Management LLC Trims Stock Position in Option Care Health, Inc. $OPCH

Key Points

• Voya Investment Management LLC decreased its stake in **Option Care Health, Inc.** by **28.8%**, selling **91,938 shares** during the first quarter, now holding **227,399 shares** valued at approximately **$7.95 million**.
• Despite the decrease in Voya's stake, other institutional investors have significantly increased their holdings, with **Northwestern Mutual Wealth Management** raising its stake by **1,492.9%** in the same period.
• **Option Care Health** reported earnings of **$0.41 EPS**, surpassing analysts' expectations, and has set FY 2025 guidance at **1.650-1.720 EPS**, reflecting strong revenue growth with a **15.4%** year-over-year increase.

Voya Investment Management LLC lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 28.8% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 227,399 shares of the company's stock after selling 91,938 shares during the period. Voya Investment Management LLC owned 0.14% of Option Care Health worth $7,948,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Compass Wealth Management LLC increased its stake in Option Care Health by 8.9% in the 1st quarter. Compass Wealth Management LLC now owns 166,078 shares of the company's stock worth $5,804,000 after buying an additional 13,600 shares in the last quarter. Bessemer Group Inc. increased its stake in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after buying an additional 599 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in shares of Option Care Health by 1.4% during the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company's stock valued at $16,981,000 after purchasing an additional 6,616 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock valued at $289,000 after purchasing an additional 1,691 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of Option Care Health by 307.1% during the 1st quarter. GAMMA Investing LLC now owns 3,192 shares of the company's stock valued at $112,000 after purchasing an additional 2,408 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Analysts Set New Price Targets

Several research analysts have commented on OPCH shares. JMP Securities increased their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a report on Thursday, July 31st. Citigroup reissued an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Finally, Barrington Research reissued an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. Eight analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $35.75.

Insiders Place Their Bets

In other news, Director Timothy P. Sullivan acquired 20,000 shares of the firm's stock in a transaction on Thursday, August 21st. The stock was acquired at an average price of $27.51 per share, with a total value of $550,200.00. Following the completion of the purchase, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Norman L. Wright acquired 3,411 shares of the firm's stock in a transaction on Tuesday, September 9th. The stock was purchased at an average cost of $29.31 per share, with a total value of $99,976.41. Following the purchase, the director owned 15,501 shares of the company's stock, valued at $454,334.31. The trade was a 28.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 59,411 shares of company stock valued at $1,627,576 over the last 90 days. Insiders own 0.64% of the company's stock.

Option Care Health Trading Down 0.4%

Shares of NASDAQ:OPCH traded down $0.10 during trading on Friday, reaching $28.31. The company's stock had a trading volume of 3,364,853 shares, compared to its average volume of 1,727,872. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The firm's 50 day simple moving average is $28.83 and its two-hundred day simple moving average is $31.21. The stock has a market capitalization of $4.59 billion, a PE ratio of 22.65, a price-to-earnings-growth ratio of 1.72 and a beta of 0.83.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The firm's revenue for the quarter was up 15.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.